Earl Zeitlin
Neurology · West Nyack, NYNPI 1629130679
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.1% of the total across 106 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 27 manufacturers reported payments, led by AbbVie at 31.9% of the total. Reporting peaked in 2019 at $950 and has fallen 80.7% since, to $183 in 2025.
Across 106 payments — averaging $18.07 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$611
- Novartis$186
- Acadia Pharmaceuticals Inc$150
- Amgen$135
- Sanofi$119
- Lilly USA, LLC$69
- plus $646 from 21 others
What the payments were for
- Speaking & faculty fees$181%
- Food & beverage$1,89899%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 32 | $611 |
| Novartis | 12 | $186 |
| Acadia Pharmaceuticals Inc | 8 | $150 |
| Amgen | 7 | $135 |
| Sanofi | 5 | $119 |
| Lilly USA, LLC | 5 | $69 |
| Supernus Pharmaceuticals, Inc. | 3 | $62 |
| Kyowa Kirin, Inc. | 3 | $60 |
| Abbott | 2 | $47 |
| Eisai Inc. | 2 | $44 |
| Arbor Pharmaceuticals, Inc. | 3 | $43 |
| Pfizer | 3 | $41 |
| EMD Serono, Inc. | 2 | $39 |
| UCB, Inc. | 2 | $37 |
| Vertical Pharmaceuticals, LLC | 2 | $36 |
| Adamas Pharmaceuticals, Inc. | 2 | $28 |
| Upsher-smith Laboratories LLC | 2 | $27 |
| Sunovion Pharmaceuticals Inc. | 2 | $26 |
| MDD US Operations, LLC | 1 | $23 |
| Lundbeck LLC | 1 | $22 |
| AstraZeneca | 1 | $21 |
| Acorda Therapeutics, Inc | 1 | $18 |
| Mallinckrodt Hospital Products Inc. | 1 | $16 |
| Bausch Health US, LLC | 1 | $15 |
| Promius Pharma LLC | 1 | $15 |
| Teva Pharmaceuticals USA, Inc. | 1 | $15 |
| Assertio Therapeutics, Inc. | 1 | $13 |
How this compares
$1,915 in reported general payments places this provider in the 60th percentile of 1,623 neurology providers in New York.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JardianceEmpagliflozin | 12 | $7,229 |
| Lamotrigine | 12 | $318 |
| Alfuzosin Hcl ErAlfuzosin Hcl | 11 | $208 |
| Tadalafil | 11 | $88 |
Paid to pharmacies, not to this prescriber.
Other neurology in West Nyack
- Idan SharonBrooklyn$2.1M
- Allan PerelStaten Island$1.7M
- Nicolas SaikaliAmherst$1.5M
- David KreitzmanCommack$1.5M
- Charles ArgoffAlbany$1.2M
- Stephen KriegerNew York$1.1M
- Robert FeketeHawthorne$1M
- Jennifer McVigeAmherst$982K
- Warren SpinnerPort Jefferson Station$791K
- Richard LiptonBronx$753K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.